Skip to main content
. Author manuscript; available in PMC: 2022 Feb 2.
Published in final edited form as: Circ Heart Fail. 2021 Feb 2;14(2):e006107. doi: 10.1161/CIRCHEARTFAILURE.119.006107

Table 2. Clinical and Demographic Characteristics of Heart Transplant Recipients, by Age and Race.

Cells include # (%) unless otherwise specified.

Black Recipients Non-Black Recipients All Recipients
Age categories 18–30 31–40 41–60 61–80 18–30 31–40 41–60 61–80

n 514 593 2,559 928 1,274 1,494 9,106 6,529 22,997
Age* 25 (21, 28) 36 (34, 39) 52 (47, 56) 64 (62, 67) 24 (21, 27) 36 (34, 39) 54 (49, 57) 65 (63, 67) 56 (46, 62)
Female 201 (39.1) 215 (36.3) 825 (32.2) 304 (32.8) 489 (38.4) 522 (34.9) 2,103 (23.1) 1,112 (17.0) 5,771 (25.1)
Insurance Type
 Medicaid insurance 257 (50.0) 182 (30.7) 430 (16.8) 60 (6.5) 342 (26.8) 270 (18.1) 997 (10.9) 246 (3.8) 2,784 (12.1)
 Medicare insurance 70 (13.6) 168 (28.3) 907 (35.4) 521 (56.1) 126 (9.9) 260 (17.4) 2,171 (23.8) 3,423 (52.4) 7,646 (33.2)
 Private insurance 162 (31.5) 213 (35.9) 1,105 (43.2) 308 (33.2) 719 (56.4) 902 (60.4) 5,623 (61.8) 2,649 (40.6) 11,681 (50.8)
 Other 25 (4.9) 30 (5.1) 117 (4.6) 39 (4.2) 87 (6.8) 62 (4.1) 315 (3.5) 211 (3.2) 886 (3.9)
College education 186 (36.2) 261 (44.0) 1,128 (44.1) 448 (48.3) 554 (43.5) 788 (52.7) 4,359 (47.9) 3,533 (54.1) 11,257 (48.9)
Body mass index* 26.3 (22.2, 31.4) 28.4 (24.2, 32.7) 27.7 (24.1, 31.6) 26.4 (23.4, 29.7) 23.9 (20.6, 28.6) 26.2 (22.6, 30.5) 27.3 (24.0, 30.9) 26.6 (23.8, 29.7) 26.9 (23.6, 30.5)
Diagnosis
 Cardiomyopathy 479 (93.2) 575 (97.0) 2,445 (95.5) 866 (93.3) 1,003 (78.7) 1,269 (84.9) 8,255 (90.7) 5,959 (91.3) 20,851 (90.7)
  Ischemic dilated 17 (3.3) 39 (6.6) 531 (20.8) 288 (31.0) 32 (2.5) 170 (11.4) 3,520 (38.7) 3,564 (54.6) 8,161 (35.5)
  Non-ischemic dilated 444 (86.4) 523 (88.2) 1,828 (71.4) 514 (55.4) 853 (67.0) 990 (66.3) 4,208 (46.2) 2,149 (32.9) 11,509 (50.0)
  Restrictive 5 (1.0) 4 (0.7) 68 (2.7) 58 (6.2) 37 (2.9) 37 (2.5) 266 (2.9) 169 (2.6) 644 (2.8)
  Hypertrophic 13 (2.5) 9 (1.5) 18 (0.7) 6 (0.6) 81 (6.4) 72 (4.8) 261 (2.9) 77 (1.2) 537 (2.3)
 Congenital heart disease 21 (4.1) 7 (1.2) 17 (0.7) 2 (0.2) 231 (18.1) 154 (10.3) 190 (2.1) 33 (0.5) 655 (2.8)
 Coronary heart disease 1 (0.2) 2 (0.3) 39 (1.5) 45 (4.8) 8 (0.6) 27 (1.8) 386 (4.2) 368 (5.6) 876 (3.8)
 Other 13 (2.5) 9 (1.5) 58 (2.3) 15 (1.6) 32 (2.5) 44 (2.9) 275 (3.0) 169 (2.6) 615 (2.7)
Status 1A (%) 337 (65.6) 366 (61.7) 1,470 (57.4) 515 (55.5) 774 (60.8) 864 (57.8) 4,968 (54.6) 3,436 (52.6) 12,730 (55.4)
PAP,* mmHg 29 (21, 36) 30 (22, 37) 29 (22, 36) 28 (22, 35) 27 (19, 35) 26 (19, 35) 27 (20, 35) 26 (20, 34) 27 (20, 35)
Creatinine,* mg/dL 1.0 (0.8, 1.3) 1.2 (1.0, 1.4) 1.3 (1.0, 1.6) 1.3 (1.1, 1.6) 0.9 (0.7, 1.1) 1.0 (0.8, 1.3) 1.1 (0.9, 1.4) 1.2 (1.0, 1.5) 1.2 (0.9, 1.5)
Bilirubin,* mg/dL 0.9 (0.5, 1.5) 0.8 (0.5, 1.3) 0.7 (0.5, 1.2) 0.7 (0.5, 1.1) 0.8 (0.5, 1.4) 0.8 (0.5, 1.2) 0.8 (0.5, 1.2) 0.8 (0.5, 1.2) 0.8 (0.5, 1.2)
Diabetes mellitus 39 (7.6) 77 (13.0) 716 (28.0) 332 (35.8) 36 (2.8) 164 (11.0) 2,327 (25.6) 2,102 (32.2) 5,793 (25.2)
Hypertension 139 (27.0) 235 (39.6) 1,180 (46.1) 472 (50.9) 247 (19.4) 387 (25.9) 3,612 (39.7) 2,847 (43.6) 9,119 (39.7)
Ventilation 11 (2.1) 9 (1.5) 29 (1.1) 11 (1.2) 42 (3.3) 34 (2.3) 150 (1.6) 109 (1.7) 395 (1.7)
VAD/TAH 242 (47.1) 294 (49.6) 1,212 (47.4) 417 (44.9) 519 (40.7) 644 (43.1) 3,753 (41.2) 2,500 (38.3) 9,581 (41.7)
ECMO 7 (1.4) 4 (0.7) 12 (0.5) 2 (0.2) 30 (2.4) 10 (0.7) 60 (0.7) 16 (0.2) 141 (0.6)
Dialysis 14 (2.7) 13 (2.2) 55 (2.1) 22 (2.4) 32 (2.5) 25 (1.7) 178 (2.0) 81 (1.2) 420 (1.8)
Transfusion 78 (15.2) 85 (14.3) 406 (15.9) 185 (19.9) 259 (20.3) 269 (18.0) 1,711 (18.8) 1,307 (20.0) 4,300 (18.7)
*

Median (IQR).

Percentage of all listed diagnoses.

PAP = pulmonary arterial pressure.